Mighty Therapeutics and the University of Washington will use pilot data on elamipretide to design a larger trial in older ...

A Lancet Neurology study of 130 blood proteins in patients receiving lecanemab suggests amyloid clearance and cognitive ...

Lovehoney’s hormone-free MenoPulse device launches, pairing air-pulse tech with early data on symptoms and autonomic function ...

QIMA Life Sciences launches SQINGEVITY, bringing biological testing and clinical studies together to examine claims about ...

Small open-label study of ATR-258 saw fat loss, lean mass gains and better leg power, but no placebo group and just eight ...

Better U and Evernow have joined forces to pair menopause specialists with psychiatry in a nationwide telehealth service.

Forecast for rapid growth by 2033, with disease-modifying therapies driving sales – and healthcare systems confronting the cost of access.

A two-year partnership with Ultrahuman aims to connect clinical biomarkers and wearable data, bringing aging assessment into ...

Arvinas presented early biomarker data on ARV-102, an oral drug built to clear the LRRK2 protein, at a major Parkinson’s ...

GPX4-targeting therapy reduces epigenetic age markers and circulating inflammation, raising questions about effects beyond ...

Ascensia partnership puts the London healthtech’s microsensor on the road to a European launch – with ambitions that run well ...

Pharma has the podium as Novo and Lilly stop talking about GLP-1 longevity and start measuring it, bringing early aging data ...